Psoriasis (PsO)
Immunology
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
SFA TherapeuticsSFA002
Heidelberg PharmaBiologic Agent
Clinical Trials (2)
Total enrollment: 3,000 patients across 2 trials
Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients
Start: Jun 2025Est. completion: Sep 2026
Phase 2/3Not Yet Recruiting
Molecular Inflammation Board at the Center for Personalized Medicine
Start: Nov 2022Est. completion: Nov 20323,000 patients
N/ARecruiting
Related Jobs in Immunology
Regulatory Affairs Manager(Immunology), Korea
AbbVie
Seoul, Seoul
8h ago
Regional Sales Trainer - Rheumatology (Mid Atlantic/Central)
AbbVie
Remote
9h ago
Senior Area Business Specialist, Immunology - Detroit, MI - Johnson & Johnson Innovative Medicine
Johnson & Johnson
Detroit, Michigan, United States
23h ago
Product Specialist - Immunology
Johnson & Johnson
Kibbutz Shefayim, Center District, Israel
23h ago
Senior Medical Science Liaison, Dermatology - Indianapolis
Johnson & Johnson
Indianapolis, Indiana, United States
23h ago
$137K - $236K/yr
Senior Clinical Trial Physician, Rheumatology
Bristol Myers Squibb
Princeton - NJ - US
23h ago
$309K - $374K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 3,000 patients
2 companies competing in this space